{"id":"NCT01039792","sponsor":"University of California, San Francisco","briefTitle":"Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism","officialTitle":"Double Blind Placebo Controlled Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2010-01","primaryCompletion":"2013-10","completion":"2013-11","firstPosted":"2009-12-25","resultsPosted":"2017-02-24","lastUpdate":"2017-02-24"},"enrollment":57,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Autistic Disorder"],"interventions":[{"type":"DRUG","name":"Methyl B12","otherNames":["Vitamin B12","methylcobalamin"]},{"type":"DIETARY_SUPPLEMENT","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Active","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether the supplement Methyl B12 is effective in treating some of the symptoms of Autism.","primaryOutcome":{"measure":"Clinical Global Impression-Improvement (CGI-I)","timeFrame":"8 weeks","effectByArm":[{"arm":"Placebo","deltaMin":3.1,"sd":0.8},{"arm":"Active","deltaMin":2.4,"sd":0.8}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26889605"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["increased hyperactivity","mouthing","cold","trouble sleeping","fever"]}}